Cargando…

Crystal structure of the human PRPK–TPRKB complex

Mutations of the p53-related protein kinase (PRPK) and TP53RK-binding protein (TPRKB) cause Galloway-Mowat syndrome (GAMOS) and are found in various human cancers. We have previously shown that small compounds targeting PRPK showed anti-cancer activity against colon and skin cancer. Here we present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian, Ma, Xinli, Banerjee, Surajit, Chen, Hanyong, Ma, Weiya, Bode, Ann M., Dong, Zigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864929/ https://www.ncbi.nlm.nih.gov/pubmed/33547416 http://dx.doi.org/10.1038/s42003-021-01683-4

Ejemplares similares

Targeting PRPK and TOPK for skin cancer prevention and therapy
por: Roh, Eunmiri, et al.
Publicado: (2018)

Structural basis for multifunctional roles of human Ints3 C-terminal domain
por: Li, Jian, et al.
Publicado: (2020)

Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2
por: Wang, Li, et al.
Publicado: (2018)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods
por: Chen, Hanyong, et al.
Publicado: (2012)

HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E
por: Chang, Xiaoyu, et al.
Publicado: (2020)

Conformational Transition Pathways of Epidermal Growth Factor Receptor Kinase Domain from Multiple Molecular Dynamics Simulations and Bayesian Clustering
por: Li, Yan, et al.
Publicado: (2014)

Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
por: Chen, Hanyong, et al.
Publicado: (2015)

Cyclin dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway
por: Peng, Cong, et al.
Publicado: (2015)

Inhibition of LTA4H by bestatin in human and mouse colorectal cancer
por: Zhao, Simin, et al.
Publicado: (2019)

Four Is Better Than 1—Strength in Numbers!
por: Bode, Ann M., et al.
Publicado: (2016)

Precision oncology- the future of personalized cancer medicine?
por: Bode, Ann M., et al.
Publicado: (2017)

Recent advances in precision oncology research
por: Bode, Ann M., et al.
Publicado: (2018)

Chemopreventive Effects of Licorice and Its Components
por: Bode, Ann M., et al.
Publicado: (2015)

Circulating Tumor Cells: Moving Biological Insights into Detection
por: Chen, Lichan, et al.
Publicado: (2017)

Crystal Structures of Group B Streptococcus Glyceraldehyde-3-Phosphate Dehydrogenase: Apo-Form, Binary and Ternary Complexes
por: Schormann, Norbert, et al.
Publicado: (2016)

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model
por: Jin, Guoguo, et al.
Publicado: (2017)

The Daidzein Metabolite, 6,7,4'-Trihydroxyisoflavone, Is a Novel Inhibitor of PKCα in Suppressing Solar UV-Induced Matrix Metalloproteinase 1
por: Lim, Tae-Gyu, et al.
Publicado: (2014)

Crystal structure of the Rous sarcoma virus intasome
por: Yin, Zhiqi, et al.
Publicado: (2016)

PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts
por: Sheng, Yuqiao, et al.
Publicado: (2016)

The Hormel Institute International Cancer Research Conference—2017 meeting report
por: Rai, Tia, et al.
Publicado: (2018)

Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability
por: Wen, Weihong, et al.
Publicado: (2013)

Veratramine modulates AP-1-dependent gene transcription by directly binding to programmable DNA
por: Bai, Fang, et al.
Publicado: (2018)

RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation
por: Yao, Ke, et al.
Publicado: (2018)

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells
por: Zhang, Yi, et al.
Publicado: (2015)

Precision medicine: the foundation of future cancer therapeutics
por: Shin, Seung Ho, et al.
Publicado: (2017)

Addressing the challenges of applying precision oncology
por: Shin, Seung Ho, et al.
Publicado: (2017)

The PGC-1/ERR network and its role in precision oncology
por: De Vitto, Humberto, et al.
Publicado: (2019)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-κB Activity in Triple-Negative Breast Cancer Cells
por: Ma, Chaobing, et al.
Publicado: (2019)

Small molecule inhibitors of mesotrypsin from a structure-based docking screen
por: Kayode, Olumide, et al.
Publicado: (2017)

Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity
por: Zhao, Luqing, et al.
Publicado: (2012)

Data-driven prediction of complex crystal structures of dense lithium
por: Wang, Xiaoyang, et al.
Publicado: (2023)

CDK12 and PAK2 as novel therapeutic targets for human gastric cancer
por: Liu, Hui, et al.
Publicado: (2020)

Crystal structure of the polyketide cyclase from Mycobacterium tuberculosis : Polyketide cyclase crystal structure
por: Zhuang, Jie, et al.
Publicado: (2022)

A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo
por: Shin, Seung Ho, et al.
Publicado: (2017)

Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies
por: Li, Hongde, et al.
Publicado: (2018)

Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo
por: Xie, Hua, et al.
Publicado: (2012)

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
por: Shi, Xiaodan, et al.
Publicado: (2021)

Knock-down of the TIM/TIPIN complex promotes apoptosis in melanoma cells
por: Chakraborty, Abhijit, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n2qeqcnapth4b21nrfc2ro01ac